Johnson & Johnson buy dietmar99
Summary
This prediction ended on 05.11.21 with a price of €142.02. The BUY prediction by dietmar99 for Johnson & Johnson saw massive gains of 34.52%. Dividends of €16.16 are taken into consideration when calculating the performance. dietmar99 has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Johnson & Johnson | 2.780% | 2.780% | -5.581% | 2.164% |
| iShares Core DAX® | 2.112% | -0.367% | 13.466% | 16.854% |
| iShares Nasdaq 100 | -2.197% | -3.794% | 38.426% | 42.934% |
| iShares Nikkei 225® | -1.555% | -7.320% | 18.451% | 2.941% |
| iShares S&P 500 | -0.472% | -2.078% | 27.488% | 41.955% |
Comments by dietmar99 for this prediction
In the thread Johnson & Johnson diskutieren
Die zeiten sind nicht einfach
Hallo zusammen,
das Unternehmen hat eine gute Markt- und Produktbasis mit Health-Care-Produkten und ist weiter auf Wachstum programmiert. Der KGV ist relativ günstig eine Dividende gib es auch, d.h. trotz niedriger Zinsen ist das Geld etwas Wert. Und wer Zeit hat kann auch noch mit einem Kursgewinn rechnen.
Gruß Dietmar
In the thread Trading Johnson & Johnson